Regular Article
Nitrovasodilator Effects on Intraocular Pressure and Outflow Facility in Monkeys

https://doi.org/10.1006/exer.1994.1199Get rights and content

Abstract

The nitrovasodilators nitroglycerin (NTG) and hydralazine (HZN) were investigated for their effects on intraocular pressure (IOP) and outflow facility in the cynomolgus monkey eye in vivo.

Fifty microlitres of 0·1% HZN were administered topically in masked, randomized, crossover, placebo controlled trials, and by intracameral perfusion.

Both NTG and HZN decreased IOP (mean IOP decrease with NTG 4·40 ± 2·11 (S.E.M.) (±4·7, S.D.) mmHg, P < 0·01, n = 5, with HZN 3·15 ± 0·85 (S.E.M.) (±2·3, S.D.) mmHg, P = 0·01, n = 7). Outflow facility increased by 92% (P < 0·05) after intracameral bolus injection of 10-3 mol l-1 NTG, but not at lower doses. Intracameral HZN caused a significant increase in facility of outflow of 28% (P < 0·05) when perfused at a constant concentration of 10-5 mol l-5, but not at certain other concentrations.

These results demonstrate the capacity for topically applied NTG and HZN to reduce IOP in the living primate eye. They further suggest that, at certain drug doses, but not others, the IOP reduction may be mediated, in part, by an action on the outflow apparatus.

References (0)

Cited by (114)

  • Nitric oxide: a drug target for glaucoma revisited

    2019, Drug Discovery Today
    Citation Excerpt :

    Studies in nonhuman primates confirmed these results. As such, it was shown that the nitrovasodilators nitroglycerin and hydralazine decreased IOP in monkeys, an effect that was paralleled by a 92% increase in outflow facility [64]. However, the clinical use of nitrovasodilators is limited by the short half-life of NO in tissue, which makes it difficult to obtain sufficient drug concentrations at the level of the target tissue.

  • Carbonic anhydrase inhibitors as ophthalmologic drugs for the treatment of glaucoma

    2019, Carbonic Anhydrases: Biochemistry and Pharmacology of an Evergreen Pharmaceutical Target
  • The nitric oxide-guanylate cyclase pathway and glaucoma

    2018, Nitric Oxide - Biology and Chemistry
    Citation Excerpt :

    In many cases, the effect of NO on IOP is linked to the action of its downstream messenger cGMP, particularly in the conventional outflow pathway (see Fig. 1). Stimulation of the NO-GC-1-cGMP pathway via administration of NO donor compounds lowers IOP through relaxation of the TM, alteration of TM volume, and an increase in the permeability of cells in the SC [76,120–127]. In addition, increased iNOS is observed following increased perfusion pressure in the anterior segments of human donor eyes [128].

View all citing articles on Scopus
View full text